Fresenius Medical Care AG (ETR:FME – Get Free Report) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of €36.90 ($40.11) and traded as high as €39.01 ($42.40). Fresenius Medical Care shares last traded at €38.77 ($42.14), with a volume of 342,136 shares trading hands.
Fresenius Medical Care Stock Up 0.7 %
The company has a market capitalization of $11.45 billion, a PE ratio of 21.42, a P/E/G ratio of 0.42 and a beta of 0.86. The company has a debt-to-equity ratio of 77.56, a quick ratio of 0.80 and a current ratio of 1.46. The firm has a fifty day simple moving average of €36.38 and a 200-day simple moving average of €36.90.
About Fresenius Medical Care
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Read More
- Five stocks we like better than Fresenius Medical Care
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Stock Analyst Ratings and Canadian Analyst Ratings
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.